Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma...

by Akihiro Kitadate, Kentaro Narita, Kouta Fukumoto, Toshiki Terao, Takafumi Tsushima, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Youichi Machida, Kosei Matsue
Published 2020-08-01

Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas

by Rafael Hernando Reyes Marlés, José Luis Navarro Fernández, José Pablo Puertas García-Sandoval, Fernando Santonja Medina, Laroussi Mohamed Salem, Laura Frutos Esteban, José Fulgencio Contreras Gutiérrez, María Isabel Castellón Sánchez, Guadalupe Ruiz Merino, María Antonia Claver Valderas
Published 2021-09-01

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma

by Ruben I. Hack, Anton S. Becker, Beata Bode-Lesniewska, G. Ulrich Exner, Daniel A. Müller, Daniela A. Ferraro, Geoffrey I. Warnock, Irene A. Burger, Christian Britschgi
Published 2021-08-01

Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy

by András Kedves, András Kedves, András Kedves, Zoltán Tóth, Zoltán Tóth, Miklós Emri, Miklós Emri, Krisztián Fábián, Dávid Sipos, Dávid Sipos, Dávid Sipos, Omar Freihat, József Tollár, József Tollár, Zsolt Cselik, Ferenc Lakosi, Gábor Bajzik, Imre Repa, Árpád Kovács, Árpád Kovács, Árpád Kovács
Published 2020-09-01

The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients

by Vikram Rao Bollineni, Sigmund Ytre-Hauge, Ankush Gulati, Mari K. Halle, Kathrine Woie, Øyvind Salvesen, Jone Trovik, Camilla Krakstad, Ingfrid S. Haldorsen
Published 2018-12-01

Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma

by Zhou Y, Zhao Z, Li J, Zhang B, Sang S, Wu Y, Deng S
Published 2019-07-01

Utility of [18F] Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography for Staging and Therapy Response Evaluation in Pediatric Rhabdomyosarcoma: A Case Series and L...

by Ri Sa, Danyan Liu, Hongguang Zhao, Sen Hou, Qiuyu Lin, Feng Guan
Published 2020-07-01

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study

by Yannan Zhao, Cheng Liu, Yingjian Zhang, Chengcheng Gong, Yi Li, Yizhao Xie, Bingrui Wu, Zhongyi Yang, Biyun Wang
Published 2018-09-01

¹⁸F-FDG and ¹¹C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers

by Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, Paula Rodriguez-Otero, Andreas K Buck, Maria Marcos-Jubilar, Leo Rasche, Elena Prieto, K Martin Kortüm, Jesus San-Miguel, Maria J. Garcia-Velloso, Constantin Lapa
Published 2020-04-01

Prognostic Significance of Regional/Systemic Metabolic Parameters on 18F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma

by Yongjiang Li, Wenbiao Zhang, Hu Zhang, Junfeng Hu, Chao Zhou, Xu Zhang, Wei Fan
Published 2021-06-01

Prognostic Impact of Pretreatment 2-[¹⁸F]-FDG PET/CT Parameters in Primary Gastric DLBCL

by Domenico Albano, Francesco Dondi, Angelica Mazzoletti, Pietro Bellini, Raffaele Giubbini, Francesco Bertagna
Published 2021-05-01

Gnesioi filoi: the Search for George Syncellus’ and Theophanes the Confessor’s Own Words, and the Authorship of Their Oeuvre

by Andrzej Kompa
Published 2015-08-01